Down 8.7% today, more than its financial peers' 1.2%; no story names it yet.
Fell on Nov 10
Down 9% so far on Nov 10.
CYPH's Quality Score fell 4 points on Mon, Nov 9, to 3. Its week-by-week trend stopped pointing up (4 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | Moves 21.1% a day with no profit behind it |
| Latest filing | 8-K, Sep 22 |
TodayNo story names it yet.
After its last 3 reports it closed +8.2% on average, higher 2 of 3 times.
Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
CYPH is #3 of 23 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 2 | ||
| 3 | ||
| 4 | ||
| Open for its score | ||
| Open for its score |
Expected to report Wed Nov 11, before the open (tomorrow).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The change was primarily due to a $46.0 million unrealized gain on the fair value of the Company's ZEC treasury holdings during the second quarter of 2026, which are marked to market at the end of each period.”
CYPH's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“The decrease was primarily due to a decrease in clinical trial and manufacturing expenses due to the completion of the clinical trials, together with a decrease in payroll”
From its results filing (SEC filing · Aug 12)
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Aug 12, 2026 | +1.8% | -3.3% | +18.4% |
| May 14, 2026 | -1.0% | +15.4% | +22.1% |
| Mar 16, 2026 | +0.7% | +12.6% | +1.2% |
RSI 41.8, MACD below signal, below its 50-day, above its 200-day. Not scored.
3 insiders sold $889K across 3 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: CYPH is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
“The biotechnology and pharmaceutical industries are characterized by continuing technological advancement and significant competition.”
CYPH scores 3 today, which Breakaway calls Below Average. It is #3 of 23 in Crypto & Digital Assets by Quality Score, with 3 of 14 chart checks firing. Down 9% so far on Nov 10. Shares: 4.4 times the count a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CYPH scores 3 today, which Breakaway calls Below Average (0 to 5). That is #3 of 23 in Crypto & Digital Assets by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CYPH's 3.
3 insiders sold $889K across 3 filings in the last 6 months. No open-market buys on record. The newest is Khing Djien Oei, Director, who sold $662K on Sep 25. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free for 24 hours. No account. No card. Then keep going with a free account.